Sepsivac
id:
sepsivac-296-4850921
title:
Sepsivac
text:
Sepsivac is a drug developed by Cadila Pharmaceuticals to treat gram-negative sepsis. The active ingredient is heat-killed Mycobacterium w, a non-pathogenic strain of Mycobacterium. As an immunomodulatory, it modulates the immune system of the body and hence significantly reduces mortality rate in patients with gram negative sepsis. Sepsivac is a drug developed by CSIR and Cadila Pharmaceuticals under New Millennium Indian Technology Leadership Initiative (NMITLI) programme. In many cases, Seps
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Sepsivac
date created:
date modified:
2023-04-04T14:41:52Z
main entity:
{"identifier":"Q97358478","url":"https://www.wikidata.org/entity/Q97358478"}
image:
fields total:
13
integrity:
13